Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

361

HTML

2816

Figures (1-2)

154

Tables (1-4)

150

Sum=3481

Dec 7, 2010 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 7, 2010; 16(45): 5766-5772
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5766

Table 2 Clinical efficiency of newly diagnosed case

¹RECIST version 1.1;

²Survival (yes), death (no). TEA: Transarterial embolization ablation; CR: Complete response; PR: Partial response.

Citation: Gu YK, Luo RG, Huang JH, Si Tu QJ, Li XX, Gao F. Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture. World J Gastroenterol 2010; 16(45): 5766-5772
URL: https://www.wjgnet.com/1007-9327/full/v16/i45/5766.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i45.5766